Eli Lilly CEO on Fighting Obesity, Developing New Drugs

Eli Lilly CEO Dave Ricks Talks Fighting Obesity, Developing New Drugs | Bloomberg TalksПодробнее

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more productПодробнее

Eli Lilly CEO David Ricks on GLP-1 and obesity drugsПодробнее

Potential for Weight-Loss Drugs Boosts Eli LillyПодробнее

Exclusive: How Eli Lilly’s making weight loss drugs more accessibleПодробнее

Eli Lilly CEO: We know there's high demand for weight-loss drugs and we're ready to meet itПодробнее

Eli Lilly CEO talks expanding innovation past obesity drugsПодробнее

Can 'unending demand' for weight-loss drugs last? | REUTERSПодробнее

New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studiesПодробнее

Eli Lilly releases new data from potentially game-changing weight loss drug trialПодробнее

Eli Lilly launches online direct-to-consumer pharmacy to help patients get weight loss drugsПодробнее

Eli Lilly CEO on slashing insulin prices, approval timelines for weight-loss and Alzheimer's drugsПодробнее

Eli Lilly CEO: Alzheimer's drug trial shows slowed disease progression by 40-60% in early patientsПодробнее

Celebrities slammed for using diabetes, weight loss drugs by Eli LillyПодробнее

Obesity drug could help sleep apnea patients, study saysПодробнее

Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to knowПодробнее

Eli Lilly's obesity drug will be a tailwind for the stock, says BMO's Evan SeigermanПодробнее

New Eli Lilly ad discourages use of weight loss drugs for cosmetic reasonsПодробнее

Pharmaceutical giant Eli Lilly launches new website to expand patient access to key medicinesПодробнее